Surg-23. patient experience and satisfaction with dexmedetomidine in awake craniotomy for brain tumours

CONCLUSIONS:The outcome of our survey looking at the use of dexmedetomidine +/- remifentanil matches the previous study in our institution using remifentanil+/-propofol and appears to be as equally as tolerated by patients. The use of dexmedetomidine has the added benefit of little or no respiratory depression. Larger studies are required to explore the true potential of dexmedetomidine further.

Source: Neuro-Oncology - November 6, 2016 Category: Cancer & Oncology Authors: Roach, J., Weidmann, C., Chapman, R., Apostolopoulos, V., Wykes, V., Grundy, P. Tags: SURGICAL THERAPY Source Type: research